Pacific Biosciences of California, Inc. logo PACB - Pacific Biosciences of California, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $1.00 DETAILS
HIGH: $1.00
LOW: $1.00
MEDIAN: $1.00
CONSENSUS: $1.00
DOWNSIDE: 18.03%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue
Revenue 160.0 154.0 200.5 128.3 130.5 78.9 90.9 78.6 93.5 90.7 92.8 60.6 28.2 26.0 33.9 1.7 0.1 0.9 2.2
Cost of Revenue 109.3 116.7 147.7 79.3 71.7 46.3 56.3 53.5 58.8 46.6 39.3 37.2 21.8 25.0 20.8 0 0 0 0
Gross Profit 50.7 37.3 52.8 49.0 58.9 32.6 34.6 25.1 34.7 44.2 53.5 23.4 6.4 0.9 13.0 1.7 0.1 0.9 2.2
Operating Expenses
R&D Expenses 97.3 134.9 187.2 193 112.9 64.2 59.6 62.6 65.3 67.6 60.4 48.2 45.2 47.6 76.1 111.8 75.9 38.0 19.2
SG&A Expenses 141.5 175.0 169.8 160.9 124.1 72.8 75.5 63.5 59.1 47.8 45.2 38.0 38.7 47.7 46.7 30.1 12.3 7.7 6.3
Other Expenses 369.4 201.7 30.3 2.4 32.3 0 0 0.8 0.5 0.1 0.4 (0.5) 0.7 (0.1) 0 (0.1) (0.1) (0.1) (0.1)
Operating Expenses 608.2 511.6 387.2 356.2 269.3 137.0 135.1 126.1 124.4 115.4 105.6 86.3 84.0 95.3 122.8 141.9 88.2 45.7 25.6
Operating Income
Operating Income (557.6) (474.3) (334.5) (307.2) (210.4) (104.4) (100.5) (101.0) (89.8) (71.2) (29.1) (62.9) (77.5) (94.3) (109.8) (140.2) (88.1) (44.8) (23.4)
Interest Expense 7.0 13.4 14.3 14.7 12.5 0.3 2.6 2.4 2.9 3.2 2.9 2.8 2.5 0.3 0.3 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0.5 1.2 1.9
Profitability
EBITDA (34.2) (242.8) (271.1) (282.2) (250.8) 39.0 (71.6) (92.9) (80.8) (67.3) (25.1) (59.1) (71.2) (87.5) (103.3) (135.0) (84.0) (41.8) (21.8)
EBIT (539.1) (296.1) (303.8) (299.6) (262.3) 29.7 (81.5) (100.1) (89.3) (71.1) (28.8) (63.3) (76.8) (94.2) (109.1) (140.2) (88.1) (44.8) (23.4)
Income Before Tax (546.1) (309.5) (318.2) (314.2) (274.9) 29.4 (84.1) (102.6) (92.2) (74.4) (31.7) (66.2) (79.3) (94.5) (109.4) (140.2) (87.7) (43.8) (21.5)
Income Tax Expense 0.3 0.3 (11.4) 0 (93.6) 0 0 0.8 0 0 0 0 0 0 (0.4) (0.2) (0.5) 0 0
Net Income (546.4) (309.9) (306.7) (314.2) (181.2) 29.4 (84.1) (102.6) (92.2) (74.4) (31.7) (66.2) (79.3) (94.5) (109.4) (140.2) (87.7) (43.8) (21.5)
Per Share Data
EPS (Basic) -1.82 -1.13 -1.21 -1.40 -0.89 0.18 -0.51 -0.76 -0.87 -0.83 -0.42 -0.94 -1.26 -1.69 -2.03 -5.21 -113.33 -56.54 -27.81
EPS (Diluted) -1.82 -1.07 -1.21 -1.40 -0.89 0.17 -0.51 -0.76 -0.87 -0.83 -0.42 -0.94 -1.26 -1.69 -2.03 -5.21 -113.33 -56.54 -27.81
Shares Outstanding 300.0 274.5 253.6 224.6 203.6 165.2 152.5 134.9 105.7 89.1 75.6 70.5 62.8 55.7 53.9 26.9 0.8 0.8 0.8
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 63.7 55.4 179.9 325.1 460.7 81.6 29.6 18.8 62.9 16.8 89.2 78.5
Short-Term Investments 215.8 334.6 451.5 447.2 583.7 237.2 19.5 83.5 0 55.2 3.5 27.6
Net Receivables 35.4 27.5 36.6 18.8 24.2 16.8 15.3 8.6 13.4 16.4 0 0
Inventory 49.3 58.8 56.7 50.4 24.6 14.2 13.3 17.9 23.1 15.6 0 0
Other Current Assets 10.8 19.5 17.3 0.3 0.5 0.8 0.3 0 0 0.5 0 0
Total Current Assets 375.0 495.7 742.0 852.1 1,101.1 355.6 81.0 131.7 101.6 109.0 93.7 106.9
Non-Current Assets
Property, Plant & Equipment 65.8 46.6 69.0 81.3 79.1 54.9 62.9 34.1 37.9 14.6 7.1 6.0
Goodwill 317.8 317.8 462.3 410.0 410.0 0 0 0 0 0 0 0
Intangible Assets 15.1 389.6 457.0 410.2 411.0 0 0 0 0 0 0 0
Long-Term Investments 1.5 0 0 0 0 0 0 4.5 4.5 4.5 0 0
Other Non-Current Assets 8.8 10.8 15.7 13.4 5.8 3.5 4.0 0.0 0.0 9.8 0.2 0.2
Total Non-Current Assets 409.1 764.8 1,004.0 915.0 905.8 58.4 66.9 38.6 42.5 28.9 7.4 6.2
Total Assets 784.1 1,260.4 1,746.0 1,767.1 2,007.0 414.0 148.0 170.3 144.1 137.9 101.1 113.1
Current Liabilities
Account Payables 20.8 16.6 15.1 12.0 11.0 3.6 8.4 6.7 9.1 8.4 5.8 1.8
Short-Term Debt 0.4 0 0.5 1.8 1.6 0 15.9 0 0 0 0 1.3
Deferred Revenue 0 13.9 16.3 30.5 11.0 8.7 7.6 6.5 6.3 7.1 0 1.1
Other Current Liabilities 32.8 3.2 7.8 175.5 4.2 4.5 0.2 5.1 5.7 9.7 0 0
Total Current Liabilities 54.4 66.3 95.0 263.3 71.7 38.5 49.2 20.3 22.3 33.8 8.4 4.7
Non-Current Liabilities
Long-Term Debt 702.4 647.5 892.2 896.7 896.1 0 0 14.7 13.6 16.1 0 0
Deferred Tax Liabilities 0 0 0 0 (25.0) 0 0 0 0 0.4 0 0
Other Non-Current Liabilities (55.0) 19.2 20.3 1.3 198.2 0.8 0 13.8 14.6 2.0 269.8 201.8
Total Non-Current Liabilities 724.3 687.6 949.7 940.8 1,144.3 40.0 43.9 35.9 35.7 19.4 269.8 201.8
Total Liabilities 778.7 753.9 1,044.7 1,204.2 1,216.0 78.5 93.1 56.2 58.0 53.2 278.2 206.5
Stockholders' Equity
Common Stock 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0 0
Retained Earnings (2,695.3) (2,148.9) (1,839.1) (1,532.3) (1,218.1) (1,036.9) (1,066.2) (982.1) (879.7) (787.5) (192.0) (104.3)
Accumulated Other Comprehensive Income 0.5 0.4 0.2 (4.8) (1.1) 0.1 0.0 (0.0) (0.0) 0.0 0.0 0.0
Total Stockholders' Equity 5.3 506.6 701.3 562.9 791.0 335.5 54.9 114.1 86.1 84.7 (177.1) (93.4)
Total Liabilities & Equity 784.1 1,260.4 1,746.0 1,767.1 2,007.0 414.0 148.0 170.3 144.1 137.9 101.1 113.1
Debt Metrics
Total Debt 759.5 672.4 933.9 948.5 955.4 42.0 61.7 14.7 13.6 16.1 0 1.3
Net Debt 695.8 617.1 754.0 623.4 494.6 (39.6) 32.0 (4.2) (49.2) (0.7) (89.2) (77.2)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (546.4) (309.9) (306.7) (314.2) (181.2) 29.4 (84.1) (102.6) (92.2) (74.4)
Depreciation & Amortization 0 53.3 32.7 17.3 11.6 9.3 9.9 7.2 8.4 3.9
Stock-Based Compensation 0 0 0 78.6 80.7 17.5 16.4 23.2 20.4 19.6
Change in Working Capital 4.4 (40.6) (59.0) (54.0) 21.0 (2.8) (3.0) 5.7 (6.0) (18.0)
Other Non-Cash Items 430.7 91.2 77.9 9.1 50.4 (33.9) (16.8) 1.0 1.2 1.0
Operating Cash Flow (111.2) (206.1) (266.5) (263.2) (111.2) 19.5 (78.3) (66.4) (67.5) (67.9)
Investing Activities
Capital Expenditure (2.7) (6.2) (8.8) (16.9) (5.9) (1.0) (2.8) (1.9) (10.4) (8.2)
Acquisitions 0 0 (0.1) 0.2 (319.8) 0 (64.9) 0 0.0 0.0
Purchases of Investments (216.9) (498.6) (756.6) (442.8) (988.0) (373.3) (57.7) (122.2) (86.3) (95.8)
Sales/Maturities of Investments 340.1 628.8 770.1 575.8 635.2 155 122.6 85.6 95.2 89.2
Other Investing Activities (5) 0 0 (0.2) 0 0 64.9 (36.6) 0.0 0.0
Investing Cash Flow 115.4 124.0 4.6 116.1 (678.5) (219.3) 62.0 (38.4) (1.5) (14.9)
Financing Activities
Net Debt Issuance 0 (50.7) (1.8) (1.6) 895.2 (16) 0 0 (4.5) 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 (86.4) 0 (20.4) 80.4 18 9.7 8.9 7.7
Financing Cash Flow 3.4 (43.0) 116.3 9.6 1,169.6 251.8 26.5 107.2 68.8 65.9
Cash Position
Net Change in Cash 7.7 (124.2) (145.2) (137.5) 379.9 52.0 10.3 2.3 (0.3) (16.9)
Cash at Beginning 56.1 180.2 325.4 465.8 85.9 33.9 23.3 21.0 16.8 33.6
Cash at End 63.7 56.1 180.2 328.3 465.8 85.9 33.6 23.3 16.5 16.8
Free Cash Flow (113.9) (212.2) (275.4) (280.1) (117.1) 18.5 (81.1) (68.3) (78.0) (76.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Income Statement
Revenue 160.0 154.0 200.5 128.3 130.5 78.9 90.9 78.6 93.5 90.7 92.8 60.6 28.2 26.0 33.9 1.7 0.1 0.9 2.2
Gross Profit 50.7 37.3 52.8 49.0 58.9 32.6 34.6 25.1 34.7 44.2 53.5 23.4 6.4 0.9 13.0 1.7 0.1 0.9 2.2
Operating Income (557.6) (474.3) (334.5) (307.2) (210.4) (104.4) (100.5) (101.0) (89.8) (71.2) (29.1) (62.9) (77.5) (94.3) (109.8) (140.2) (88.1) (44.8) (23.4)
Net Income (546.4) (309.9) (306.7) (314.2) (181.2) 29.4 (84.1) (102.6) (92.2) (74.4) (31.7) (66.2) (79.3) (94.5) (109.4) (140.2) (87.7) (43.8) (21.5)
EPS (Diluted) -1.82 -1.07 -1.21 -1.40 -0.89 0.17 -0.51 -0.76 -0.87 -0.83 -0.42 -0.94 -1.26 -1.69 -2.03 -5.21 -113.33 -56.54 -27.81
Balance Sheet
Cash & Equivalents 63.7 55.4 179.9 325.1 460.7 81.6 29.6 18.8 62.9 16.8 89.2 78.5
Total Assets 784.1 1,260.4 1,746.0 1,767.1 2,007.0 414.0 148.0 170.3 144.1 137.9 101.1 113.1
Total Debt 759.5 672.4 933.9 948.5 955.4 42.0 61.7 14.7 13.6 16.1 0 1.3
Stockholders' Equity 5.3 506.6 701.3 562.9 791.0 335.5 54.9 114.1 86.1 84.7 (177.1) (93.4)
Cash Flow
Operating Cash Flow (111.2) (206.1) (266.5) (263.2) (111.2) 19.5 (78.3) (66.4) (67.5) (67.9)
Capital Expenditure (2.7) (6.2) (8.8) (16.9) (5.9) (1.0) (2.8) (1.9) (10.4) (8.2)
Free Cash Flow (113.9) (212.2) (275.4) (280.1) (117.1) 18.5 (81.1) (68.3) (78.0) (76.1)